Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GRCE)

CUSIP: 00439U104

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
-56,070
Put/Call ratio
123%
SEC-reported price per share
$4.63
Number of holders
34
Value change
+$1,574,724
Number of buys
21
Open additional details 1 more signal available
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
18,244,606

Security key

00439U104

Report period

Q1 2026

Institutions

34

Top holders

10

Ownership snapshot

Top reported holders of GRCE - Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ADAR1 Capital Management,...
Disclosed value leader
Nantahala Capital Managem...
Comparable rows
15/15
Latest evidence
31 Mar 2026
13F 13D/G 3/4/5 Lead comparable stake: 9.9% 13D/G row: ADAR1 Capital Management, LLC Showing 1-6 of 15 holder rows.

Quick read

ADAR1 Capital Management, LLC leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ADAR1 Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
ADAR1 Capital Management, LLC 9.9%
Orin Hirschman 4.9%
Nantahala Capital Management, LLC 6.5%
AIGH Capital Management LLC 5%
BANK OF AMERICA CORP /DE/ 2.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ADAR1 Capital Management, LLC
13F 13D/G 3/4/5
Company · ADAR1 Capital Management GP, LLC · 10%+ Owner
9.9%
from 13D/G
$2,221,278
641,988 shares
31 Dec 2025
Orin Hirschman
13D/G
4.9%
814,000 shares
$0 31 Mar 2026
Nantahala Capital Management, LLC
13F
Company
13F
6.5%
$4,076,582
1,178,203 shares
31 Dec 2025
AIGH Capital Management LLC
13F
Company
13F
5%
$3,146,077
907,217 shares
31 Dec 2025
BANK OF AMERICA CORP /DE/
13F
Company
13F
2.7%
$1,711,655
494,698 shares
31 Dec 2025
VANGUARD GROUP INC
13F
Company
13F
2.3%
$1,479,694
423,981 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
34
Shares
4,264,472
Rows available
34
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
22
Q1 2026 holders
34
Holder diff
12
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .